Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: Am J Med. 2018 Aug 1;131(12):1473–1481. doi: 10.1016/j.amjmed.2018.07.008

Table 2.

Outcomes Patients with Heart Failure with Preserved Ejection Fraction ≥50% and Heart Rate ≥70 Beats/Minute, by High-Dose Beta-Blocker Versus No Beta-Blocker Use

Events (%)
No beta-blocker (n=640) High-dose beta-blocker (n=640) Hazard ratio* (95% confidence interval)
All-cause mortality 438 (68%) 403 (63%) 0.86 (0.75–0.98); p=0.027
All-cause readmission 566 (88%) 565 (88%) 0.90 (0.81–1.02); p=0.100
Heart failure readmission 294 (46%) 287 (45%) 0.93 (0.79–1.09); p=0.362
All-cause readmission or all-cause mortality 619 (97%) 607 (95%) 0.89 (0.80–1.00); p=0.044
Heart failure readmission or all-cause mortality 522 (82%) 496 (78%) 0.90 (0.80–1.02); p=0.091
*

Associated with high-dose beta-blocker use